There are 16 resources available
Targeting KRAS Beyond G12C – What is Coming?
Presenter: E. Smit, NL
Session: Session 3 – Moving beyond KRAS G12C
Resources:
Slides
Webcast
Targeting KRAS with Checkpoint Inhibitors
Presenter: M. C. Garassino, US
Session: Session 3 – Moving beyond KRAS G12C
Resources:
Slides
Webcast
Vaccine and Adoptive Cell Therapy Strategies for the Treatment of KRAS Mutant NSCLC
Presenter: A. Sacher, CA
Session: Session 3 – Moving beyond KRAS G12C
Resources:
Slides
Webcast
Workshop 1: Liquid Biopsy Applications for RAS-mutated Mutational Profiling, Monitoring of Disease Course, Clonal Evolution and Resistance in NSCLC
Presenter: L. Mezquita, ES, N. Leighl, CA, and K. Kerr, UK
Session: Workshop Sessions
Resources:
Slides
Webcast
Workshop 2: KRAS-focused Vaccines and T Cell Therapies
Presenter: A. Sacher, CA, and C. Bestvina, US
Session: Workshop Sessions
Resources:
Slides
Webcast
Workshop 3: Designing Practice-changing Trials – Key Considerations
Presenter: G. Dy, US, C. Lindsay, UK, and M. C. Garassino, US
Session: Workshop Sessions
Resources:
Slides
Webcast